ComboMATCH Treatment Trials to Test New Drug Combinations Guided By Tumor Biology

June 18, 2024

The National Cancer Institute’s (NCI) Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH) is a large precision medicine initiative with a coordinated set of clinical trials evaluating new anti-cancer drug combinations in select groups of adults and children with cancer. Each trial is geared to studying the effectiveness of a specific drug combina

2024 Alliance Spring Hybrid Group Meeting Convenes May 15-18

May 9, 2024

Meeting book

Congratulations to the VCU Massey Cancer Center Minority Underserved NCORP for the 2024 Alliance Spring Hybrid Group Meeting Book cover design. As an awardee of a MU-NCORP (formerly referred to as Minority Community Clinical Oncology Program) for more than 30 years, Massey plays a significant role in facilitating the dev

Alliance and Natera Announce Activation of Alliance A032103 (MODERN): A Randomized, Phase II/III Adjuvant Trial in Urothelial Cancer

May 1, 2024

First of its kind study in muscle-invasive urothelial cancer, with both escalation and de-escalation arms
Approximately 1,000 patients will be enrolled at more than 300 sites

The Alliance for Clinical Trials in Oncology and Natera, Inc., a global leader in cell-free DNA testing, recently announced the launch of Alliance A032103 (MO

Older News